Ubiquitin- and proteasome-dependent pathway of protein degradation as an emerging therapeutic target

Author： Wójcik C.  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.4, Iss.1, 2000-02, pp. : 89-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein Degradation by the Ubiquitin-Proteasome Pathway and Organ Fibrosis

By  

Current Medicinal Chemistry, Vol. 19, Iss. 6, 2012-02 ,pp. : 893-900

Bentham Science Publishers

Access to resources Recommend Favorite

Proteasome as an Emerging Therapeutic Target in Cancer

By  

Current Pharmaceutical Design, Vol. 13, Iss. 5, 2007-02 ,pp. : 471-485

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Ubiquitin-Proteasome Pathway: An Emerging Concept in Cancer Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 23, 2011-12 ,pp. : 2888-2905

Bentham Science Publishers

Access to resources Recommend Favorite

Natural Products Inhibiting the Ubiquitin-Proteasome Proteolytic Pathway, A Target for Drug Development

By  

Current Medicinal Chemistry, Vol. 13, Iss. 7, 2006-03 ,pp. : 745-754

Bentham Science Publishers

Access to resources Recommend Favorite

The cAMP-Dependent Protein Kinase Pathway as Therapeutic Target - Possibilities and Pitfalls

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 11, 2011-06 ,pp. : 1393-1405

Bentham Science Publishers

Access to resources Recommend Favorite